Abstract. We examined the effects of treatment with histone deacetylase inhibitors (HDACi), trichostatin A (TSA) and scriptaid (SCR), on the blastocyst formation rate in bovine somatic cell nuclear transferred (SCNT) embryos derived from fibroblast cells. Three fibroblast cell lines (L1, L2 and L3) were used as somatic cell donors to produce SCNT embryos (L1, L2 and L3 embryos, respectively). In Experiment 1, we compared the in vitro developmental competence of L1 embryos treated with various concentrations of TSA for different time periods following chemical activation. Embryos treated with 5 nM TSA for 20 h showed a significantly increased blastocyst formation rate compared with untreated controls. In Experiment 2, we examined the effect of TSA (5 nM) treatment of L1, L2 and L3 embryos as well as the effect of treatment of L1, L2 and L3 embryos with various concentrations of SCR on in vitro developmental competence. It was found that 5 nM TSA treatment significantly increased the blastocyst formation rate in L1 and L3 embryos but did not have an influence on the development of L2 embryos. On the other hand, 5 nM SCR treatment significantly increased the blastocyst formation rates of L1 and L2 embryos compared with controls. However, there was no significant increase in the blastocyst formation rate of L3 embryos when they were treated with SCR. In Experiment 3, acetylation of H4K12 was examined in donor cells and pronuclear-stage L1, L2 and L3 embryos treated with 5 nM TSA or 5 nM SCR by immunostaining. The level of H4K12 acetylation was different among donor cells. The staining intensities in the TSA-treated L1 and L3 embryos and SCR-treated L2 embryos were significantly higher than those of untreated embryos. These results suggest that HDACi treatment of bovine SCNT embryos improves the blastocyst formation rate; however, the optimal treatment conditions may differ among donor cell lines. Key words: Bovine, Nuclear transfer, Histone deacetylase inhibitor (J. Reprod. Dev. 57: [120][121][122][123][124][125][126] 2011) ive cloned offspring have been produced in many species by somatic cell nuclear transfer (SCNT), although the cloning efficiency is still very low. It has been reported that, in SCNT, embryo losses occur at various stages, and the anomalies in fetal and perinatal stages have been observed [1][2][3][4][5][6]. Because such abnormalities of clones are not transmitted to their progenies [7][8][9][10][11][12], most of the developmental problems of clones are believed to be the results of epigenetic defects [13]. In fact, several studies have revealed abnormal epigenetic modifications such as DNA methylation and histone modifications in SCNT embryos [14][15][16][17].A wide variety of histone deacetylase inhibitors (HDACi) of both natural and synthetic origin has been reported [18]. Trichostatin A (TSA), which is a natural product isolated from Streptomyces hygroscopicus [19], is one of the most frequently used drugs for various studies as a selective HDACi. Recently, it has been reported from two la...